Enanta Pharmaceuticals, Inc. (9EP)
Market Open
23 Oct, 07:56 PM
XSTU 
€
10. 30
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
592 Volume
-5.15 Eps
€ 10.3
Previous Close Want to track 9EP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
9EP Earnings Reports FAQ
What is the earnings per share (EPS) for 9EP?
The current EPS is -5.15.
What is the company's earnings growth rate?
Enanta Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Enanta Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Enanta Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 9EP at this time, as Enanta Pharmaceuticals, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
